Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Daiichi Sankyo
Novartis
Julphar
UBS
Colorcon
Queensland Health
McKesson
Teva
Healthtrust

Generated: February 24, 2018

DrugPatentWatch Database Preview

CAVERJECT Drug Profile

« Back to Dashboard

Which patents cover Caverject, and when can generic versions of Caverject launch?

Caverject is a drug marketed by Pfizer and Pharmacia And Upjohn and is included in three NDAs.

The generic ingredient in CAVERJECT is alprostadil. There are seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the alprostadil profile page.
Summary for CAVERJECT
Drug patent expirations by year for CAVERJECT
Medical Subject Heading (MeSH) Categories for CAVERJECT

US Patents and Regulatory Information for CAVERJECT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer CAVERJECT alprostadil INJECTABLE;INJECTION 020755-001 Oct 31, 1997 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn CAVERJECT alprostadil INJECTABLE;INJECTION 020379-004 May 19, 1997 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn CAVERJECT alprostadil INJECTABLE;INJECTION 020379-003 Jun 27, 1996 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn CAVERJECT IMPULSE alprostadil INJECTABLE;INJECTION 021212-001 Jun 11, 2002 RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pfizer CAVERJECT alprostadil INJECTABLE;INJECTION 020755-002 Oct 1, 1997 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pfizer CAVERJECT alprostadil INJECTABLE;INJECTION 020755-003 Oct 1, 1997 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn CAVERJECT alprostadil INJECTABLE;INJECTION 020379-002 Jul 6, 1995 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn CAVERJECT alprostadil INJECTABLE;INJECTION 020379-001 Jul 6, 1995 AP RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn CAVERJECT IMPULSE alprostadil INJECTABLE;INJECTION 021212-002 Jun 11, 2002 RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for CAVERJECT

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn CAVERJECT alprostadil INJECTABLE;INJECTION 020379-003 Jun 27, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn CAVERJECT alprostadil INJECTABLE;INJECTION 020379-002 Jul 6, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn CAVERJECT alprostadil INJECTABLE;INJECTION 020379-002 Jul 6, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn CAVERJECT alprostadil INJECTABLE;INJECTION 020379-004 May 19, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn CAVERJECT alprostadil INJECTABLE;INJECTION 020379-001 Jul 6, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn CAVERJECT alprostadil INJECTABLE;INJECTION 020379-001 Jul 6, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Citi
McKinsey
US Department of Justice
Cantor Fitzgerald
Farmers Insurance
US Army
Johnson and Johnson
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot